VanHimbergen Robert M 4

What Happened
Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health Inc. (ELAN), received an award of 7.622 deferred stock units on February 20, 2026. The units are valued at $24.98 each for a total reported value of approximately $190. The transaction is reported as an award/grant (transaction code A) and is a derivative instrument (deferred stock units), not an immediate open-market purchase.

Key Details

• Transaction date: 2026-02-20; Form 4 filed: 2026-02-24 (filed within required reporting window).
• Award: 7.622 deferred stock units at $24.98 per unit; total value ≈ $190.
• Transaction type/code: Grant/award (A); classified as a derivative.
• Shares owned after transaction: Not specified in the filing.
• Footnotes:
  • F1: Each deferred stock unit represents the right to receive one share of Elanco common stock or the cash equivalent.
  • F2: Deferred stock units settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Context
Deferred stock units are a form of compensation that give the holder a right to future stock or cash settlement and do not necessarily convey immediate voting rights or market exposure. This award is small in dollar terms (~$190) and appears to be a routine compensation grant rather than a market-direction trade.